Methylphenidate for pervasive developmental disorders: Safety and efficacy of acute single dose test and ongoing therapy: An open-pilot study

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 2, 2004, Pages 207-218

  Di Martino, Adriana ^b   Melis, Gianluigi ^a   Cianchetti, Carlo ^a   Zuddas, Alessandro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ACUTE DRUG ADMINISTRATION; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CHILD PSYCHIATRIC AND CONNER PARENT AND TEACHER RATING SCALE; CHILDHOOD AUTISM SCORE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; MAXIMUM TOLERATED DOSE; OPEN STUDY; PILOT STUDY; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; STEREOTYPY; TIC;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MENTAL RETARDATION; METHYLPHENIDATE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; STEREOTYPED BEHAVIOR;

EID: 3342976049     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/1044546041649011     Document Type: Article

References (39)

1. Aman M: The use of methylphenidate in autism. J Am Acad Child Adolesc Psychiatry 27:821-822, 1988.
2. Aman MG, Langworthy KS: Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 30:451-459, 2000.
3. Aman MG, Pejeau C, Osborne P, Rojahn J, Handen B: Four-year follow-up of children with low intelligence and ADHD. Res Dev Disabil 17:417-432, 1996.
4. Aman MG, Van Bourgondien ME, Wolford PL, Sarphare G: Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use. J Am Acad Child Adolesc Psychiatry 34:1672-1681, 1995.
5. American Psychiatric Association (APA): Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC, American Psychiatric Association, 1994.
6. Birmaher B, Quintana H, Greenhill LL: Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 27:248-251, 1988.
7. Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C: Response to tri-iodothyronine and dextroamphetamine: A study of preschool schizophrenic children. J Autism Child Schizophr 2:343-358, 1972.
8. Campbell M, Palij M: Behavioral and cognitive measures used in psychopharmacological studies of infantile autism. Psychopharmacol Bull 21: 1047-1053, 1985.
9. Campbell M, Small AM, Collins PJ, Friedman E, David R, Genieser N: Levodopa and levoamphetamine: A crossover study in young schizophrenic children. Curr Ther Res Clin Exp 19: 70-86, 1976.
10. Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD, Rapoport JL: Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36: 589-596, 1997.
11. Conners CK: Conner's Rating Scales - Revised User's Manual. North Tonawanda, NY, Multi-Health Systems, Inc., 1997.
12. DiLalla DL, Rogers SJ: Domains of the Childhood Autism Rating Scale: Relevance for diagnosis and treatment. J Autism Dev Disord 24:115-128, 1994.
13. Geller B, Guttmacher LB, Bleeg M: Coexistence of childhood onset pervasive developmental disorder and attention-deficit disorder with hyperactivity. Am J Psychiatry 138:388-389, 1981.
14. Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S: Adverse side effects of methylphenidate among mentally retarded children with ADHD. J Am Acad Child Adolesc Psychiatry 30:241-245, 1991.
15. Handen BL, Johnson CR, Lubetsky M: Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord 30:245-255, 2000.
16. Langworthy-Lam KS, Aman MG, Van Bourgondien ME: Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. J Child Adolesc Psychopharmacol 12:311-321, 2002.
17. Lovaas OI, Koegel RL, Schreibman L: Stimulus overselectivity in autism: A review of research. Psychol Bull 86:1236-1254, 1979.
18. Martin A, Scahill L, Klin A, Volkmar FR: Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. J Am Acad Child Adolesc Psychiatry 38:923-931, 1999.
19. McDougle CJ, Posey D: Genetics of childhood disorders: XLIV. Autism, part 3: Psychopharmacology of autism. J Am Acad Child Adolesc Psychiatry 41:1380-1383, 2002.
20. MTA: A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56:1073-1086, 1999.
21. Mundry R, Fischer J: Use of statistical programs for nonparametric tests of small samples often leads to incorrect p values: Examples from Animal Behavior. Animal Behavior 56:256-259, 1998.
22. Nicolson R, Castellanos FX: Commentary: Considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 30:461-462, 2000.
23. NIMH: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:1077-1080, 1985a.
24. NIMH: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:839-843, 1985b.
25. Overall JE, Campbell M: Behavioral assessment of psychopathology in children: Infantile autism. J Clin Psychol 44:708-716, 1988.
26. Quintana H, Birmaher B, Stedge D, Lennon S, Freed J, Bridge J, Greenhill L: Use of methylphenidate in the treatment of children with autistic disorder. J Autism Dev Disord 25:283-294, 1995.
27. Realmuto GM, August GJ, Garfinkel BD: Clinical effect of buspirone in autistic children. J Clin Psychopharmacol 9:122-125, 1989.
28. Roid G, Miller L: Leiter international performance scale-revised: Examiners manual. Wood Dale, IL, Stoelting Co., 1996.
29. Santosh PJ, Taylor E: Stimulant drugs. Eur Child Adolesc Psychiatry 9 (Suppl 1):I27-I43, 2000.
30. Schmidt K: The effect of stimulant medication in childhood-onset pervasive developmental disorder - a case report. J Dev Behav Pediatr 3: 244-246, 1982.
31. Schopler E, Reichler RJ, DeVellis RF, Daly K: Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 10:91-103, 1980.
32. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (CGAS). Arch Gen Psychiatry 40: 1228-1231, 1983.
33. Spencer T, Biederman J, Wilens TE, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432, 1996.
34. Sporn A, Pinsker H: Use of stimulant medication in treating pervasive developmental disorder. Am J Psychiatry 138:997, 1981.
35. Strayhorn J: More on methylphenidate in autism. J Am Acad Child Adolesc Psychiatry 28:299, 1989.
36. Vitriol C, Farber B: Stimulant medication in certain childhood disorders. Am J Psychiatry 138:1517-1518, 1981.
37. Volkmar FR, Hoder EL, Cohen DJ: Inappropriate uses of stimulant medications. Clin Pediatr (Phila) 24:127-130, 1985.
38. Wechsler D: Manual for the Wechsler Preschool and Primary Scale of Intelligence. New York, Psychological Corporation, 1967.
39. Wechsler D: Wechsler intelligence scale for children - revised manual. New York, Psychological Corporation, 1974.